Back to Reports
Author: Bonitas Research Ticker: PETS Company: PetMed Express

Pets At Home Group (London: PETS)

Bonitas Research exposes Pets at Home's £34M hidden trading loans, alleging 75% stock crash potential through circular payment schemes, JV financial misrepresentation, and unsustainable accounting practices in UK pet retail sector

3 min read

Bonitas Research has released a scathing report on Pets at Home Group Plc (LSE: PETS), alleging the UK pet care retailer concealed millions in trading loans to prop up failing joint ventures while artificially inflating its profits through a circular payment scheme.


Ticker: PETS (LSE)
Research Firm: Bonitas Research
Report URL: https://www.bonitasresearch.com/company/pets-home-group-london-pets/
Position Disclosure: Bonitas Research holds a short position in Pets at Home Group (LSE: PETS).


Why It Matters

  • Hidden Liabilities: Pets at Home concealed £34 million in trading loans to its joint ventures (JVs), with actual funding being 87% (FY'18) and 51% (FY'19) higher than reported
  • Circular Payment Scheme: The company charged unsustainable service fees to its JVs that could only be paid through hidden financial support, creating artificial profits
  • Failing JV Network: 69% of operational JVs were balance sheet insolvent with collective net liabilities of £170 million by FY'19
  • High-Risk Accounting: Service fees from mostly unprofitable JVs represented only 6% of revenues but generated 31% of operating profits with suspiciously high 50%+ margins
  • Restructuring Costs Mounting: Already spent £40+ million on JV bailouts through "step-up acquisitions," with more write-offs likely as JV finances deteriorate further
  • Overvalued Goodwill: £395 million in goodwill primarily linked to anticipated cash flows from failing JVs appears significantly overstated

By The Numbers

  • Pets at Home has become the largest lender to its JV network, contradicting claims that third-party banks were the primary funding source
  • The company's retail segment produced only 8% margins while JV service fees generated over 50% margins through the circular payment arrangement
  • 61% of operating PETS JVs generated aggregate losses of £27 million in FY'18, exposing the unsustainable nature of the business model
  • JV net liabilities grew dramatically from £68 million in FY'17 to £117 million in FY'19, a 71% increase
  • Bonitas projects a potential 75%+ downside for PETS stock when accounting for the true state of its balance sheet and earnings quality

FAQs

What exactly is Pets at Home accused of doing?

Bonitas Research alleges that Pets at Home concealed £34 million in trading loans to its joint ventures while creating an artificial profit center through service fees that these JVs could only pay because of the hidden financial support.

What is a "circular payment scheme" in this context?

It's an arrangement where Pets at Home provided hidden loans to its struggling JVs, which then used this money to pay inflated service fees back to Pets at Home, creating the illusion of high-margin revenue while masking the true financial condition of the JVs.

How many of Pets at Home's joint ventures are actually profitable?

According to the report, 61% of operating PETS JVs were loss-making in FY'18, and by FY'19, 69% were balance sheet insolvent with collective net liabilities of approximately £170 million.

What is a "step-up acquisition" and why is it significant?

This is when Pets at Home fully acquires a previously jointly-owned venture. The report notes that these acquisitions have already cost the company over £40 million in write-offs and expenses as it assumes all the JVs' liabilities.

How does this affect Pets at Home's reported profits?

The report claims that about 31% of Pets at Home's underlying operating profits in FY'18 and FY'19 came from service fees charged to these financially distressed JVs, suggesting that nearly a third of the company's profits depend on this questionable arrangement.

What could happen to Pets at Home's stock price?

Bonitas Research projects a potential downside of over 75% for PETS' stock price when accounting for the alleged misrepresentations, hidden liabilities, and likely future write-offs.

Does Pets at Home deny these allegations?

The report was just released, and at the time of this summary, there has been no official response from Pets at Home to these specific allegations.


Disclaimer: This summary is not primary research and does not constitute investment advice. It is a brief overview of a detailed equity research report authored by the firm, organization, or source referenced in this article or at https://www.bonitasresearch.com/company/pets-home-group-london-pets/, which contains extensive evidence, regulatory filings, and analysis; readers are encouraged to review the full report there for a comprehensive understanding. The content provided in this publication is not authored or originated by us — we act solely as a distributor and do not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of the information presented. This publication is for informational purposes only and should not be construed as legal, business, investment, or tax advice. Always conduct independent due diligence and consult qualified professionals before making any decisions based on the information contained herein. We disclaim all liability for any loss or damage arising from reliance on third-party content, and the views expressed are solely those of the respective source and do not necessarily reflect our own.

Related Research

View full archive

The Signal. No Noise.

Join 50,000+ investors receiving our weekly synthesis.